Core Viewpoint - The company, RIBON Instruments (300206.SZ), forecasts a significant increase in net profit for the year 2025, indicating strong growth in both domestic and international markets [1] Financial Performance - The company expects net profit attributable to shareholders to be between 284 million to 332 million yuan, representing a year-on-year growth of 75% to 105% [1] - The net profit after deducting non-recurring gains and losses is projected to be between 273 million to 316 million yuan, with a year-on-year increase of 90% to 120% [1] Revenue Growth - Overall operating revenue is anticipated to grow steadily in 2025, with notable double-digit growth in international markets [1] - The patient monitoring and ultrasound imaging segments are expected to show particularly significant growth [1]
理邦仪器(300206.SZ)发预增,预计2025年度归母净利润2.84亿元至3.32亿元,增长75%至105%